3Q Revenues: $294.1 million (+44%)
3Q Earnings: $92.2 million (+41%)
YTD Revenues: $813.6 million (+46%)
YTD Earnings: $173.9 million (+37%)
Comments: Soliris sales were $294.1 million in the quarter, up 44%. R&D expenses were $54.3 million, compared to $36.6 million in 3Q11. Results were positively impacted by the terms of a patent settlement and license agreement, for which the company recognized a gain of $53.4 million in cost of sales, net of the effect of an upfront payment.